Pee Cee Cosma Sope (Small Cap - Potential Multibagger) Share Target 2025, 2026 To 2035
|
Pee Cee Cosma Sope Limited |
|||
|
Price: ₹612.00 (+0.5%) | ||
| 52 Week Low: ₹302.15 52 Week High: ₹978.60 |
|||
| Market Capital: 109.91 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Pee Cee Cosma Sope Share Price Target For 2025
- 1.1.1: Pee Cee Cosma Sope Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Pee Cee Cosma Sope Share Price Target For 2026
- 1.2.1: Pee Cee Cosma Sope Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Pee Cee Cosma Sope Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Pee Cee Cosma Sope Financial Performance
- 3.0.1: Is Pee Cee Cosma Sope A Good Buy For Long Term?
Pee Cee Cosma Sope, a Small Cap company has delivered 620.4% returns in 5-year showing 3.8% quarterly revenue growth with 21.6% profit margin, making it a potential Multibagger.
To predict the Pee Cee Cosma Sope's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Pee Cee Cosma Sope Share Price Target For 2025
The line chart displays the monthly closing prices of Pee Cee Cosma Sope with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Pee Cee Cosma Sope shares in 2025, see the table below.
Pee Cee Cosma Sope Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 732.65 (+19.71%) | Price Action: 30 Sep 2024 High |
| 2025 Target 2 | 725.0 (+18.46%) | Price Action: 19 Nov 2024 High |
| 2025 Target 1 | 710.0 (+16.01%) | Price Action: 24 Sep 2024 Low |
| Current Price | 612.00 | Pee Cee Cosma Sope's share price as of 23 Jan 2025 |
| Stop Loss 1 | 566.15 (-7.5%) | Price Action: 03 Sep 2024 Low |
| Stop Loss 2 | 556.5 (-9.07%) | Price Action: 27 Aug 2024 Low |
| Stop Loss 3 | 549.66 (-10.19%) | Price Action: Sep 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Pee Cee Cosma Sope is showing mixed momentum signals near key moving averages.
Key Technical Level: The 25-day moving average at ₹600.53 serves as the nearest technical reference point.
Historical Returns: 3-month: -24.31% | 6-month: +39.6% | 1-year: +93.26%
Pee Cee Cosma Sope Share Price Target For 2026
The line chart displays the monthly closing prices of Pee Cee Cosma Sope with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Pee Cee Cosma Sope shares in 2026, see the table below.
Pee Cee Cosma Sope Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 1224.17 (+100.02%) | Price Action: Chart |
| 2026 Target 2 | 1201.34 (+96.29%) | Price Action: Chart |
| 2026 Target 1 | 1189.45 (+94.35%) | Fibonacci Extension Level 123.60% |
| Current Price | 612.00 | Pee Cee Cosma Sope's share price as of 23 Jan 2025 |
| Stop Loss 1 | 479.0 (-21.74%) | Price Action: 22 Nov 2023 High |
| Stop Loss 2 | 470.6 (-23.11%) | Price Action: 24 Jul 2024 High |
| Stop Loss 3 | 464.0 (-24.19%) | Price Action: 20 Jun 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Pee Cee Cosma Sope is currently trading at 45.8% of its 52-week range (₹302.15 - ₹978.6).
Long-Term Trend Analysis: The stock shows mixed long-term signals, trading near key moving averages.
Long-Term Performance: 1-year: +93.26% | 3-year: +344.61% | 5-year: +620.41%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Pee Cee Cosma Sope Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹612.00 | ||
| 2025 | ₹875.83 | +43.1% | ₹888.97 |
| 2026 | ₹1,371.92 | +56.64% | ₹1,392.50 |
| 2027 | ₹1,788.42 | +30.35% | ₹1,815.25 |
| 2028 | ₹2,509.63 | +40.32% | ₹2,547.27 |
| 2029 | ₹3,457.87 | +37.78% | ₹3,509.74 |
| 2030 | ₹4,383.49 | +26.76% | ₹4,449.24 |
| 2031 | ₹5,993.05 | +36.71% | ₹6,082.95 |
| 2032 | ₹8,010.03 | +33.65% | ₹8,130.18 |
| 2033 | ₹9,962.82 | +24.37% | ₹10,112.26 |
| 2034 | ₹12,172.36 | +22.17% | ₹12,354.95 |
| 2035 | ₹15,639.62 | +28.48% | ₹15,874.21 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Pee Cee Cosma Sope Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 109.91 Crore | Market valuation of Pee Cee Cosma Sope's shares. |
| Revenue (TTM) | 124.51 Crore | Total revenue generated by Pee Cee Cosma Sope over the past twelve months. |
| Net Income (TTM) | +2.48 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +3.36% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +21.65% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+3.76% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
0.14 | Company's total debt divided by total shareholder equity. |
| Total Debt | 5.21 Crore | Sum of Pee Cee Cosma Sope's current & long-term financial obligations. |
Is Pee Cee Cosma Sope A Good Buy For Long Term?
Pee Cee Cosma Sope presents promising long-term prospects. With an impressive revenue growth of 3.76% from the previous quarter and a healthy profit margin of 21.65%, the company's financial health is robust. Its exceptional performance is evident in its remarkable returns over the past 3, 5, and 12 months, showcasing the stock's potential for appreciation. Despite a moderate decline in returns over the past 6 months, the company's solid fundamentals and promising outlook make it an attractive investment for long-term growth.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
